<?xml version="1.0" encoding="Windows-31J"?>
<ArticleSet xmlns="http://www.openarchives.org/OAI/2.0/">
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>大腸菌のペニシリン誘導フィラメント細胞におけるアミノ酸能動輸送能変化</ArticleTitle>
    <FirstPage LZero="delete">575</FirstPage>
    <LastPage>581</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Nobuaki</FirstName>
        <LastName>Naito</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Ken-ichi</FirstName>
        <LastName>Tomochika</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Akira</FirstName>
        <LastName>Kumode</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Junji</FirstName>
        <LastName>Shiode</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Yasuhiro</FirstName>
        <LastName>Kanemasa</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>最少発育阻止濃度以下のぺニシリンGにより誘導した大腸菌フィラメント細胞のアミノ酸能動輸送能の測定を行った.各種アミノ酸の能動輸送能は細胞の伸長に伴い低下したが,特にosmotic shock resistant基質においてその低下が著しかった.α-MGやTPMP(+)の取り込み能は,ぺニシリン処理の影響をほとんど受けなかった.このことから,アミノ酸能動輸送能の低下は,そのエネルギー源の消失によるのではなく,原形質膜中のアミノ酸能動輸送担体の分布またはその量的変化に起因することが示唆された.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">アミノ酸能動輸送</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ペニシリン</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">フィラメント細胞</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">膜ポテンシャル</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>僧帽弁狭窄症の術後左心機能と運動耐容能よりみた至適術式の選択</ArticleTitle>
    <FirstPage LZero="delete">555</FirstPage>
    <LastPage>573</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Katsumi</FirstName>
        <LastName>Motohiro</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>There are two major surgical procedures for pure or predominant mitral stenosis, open mitral commissurotomy (OMC) and mitral valve replacement (MVR). The purpose of this study was to assess the left ventricular (LV) function and exercise tolerance after mitral surgery by these procedures. Forty-eight patients underwent mitral valve surgery, and were divided into 3 groups, namely, Sellors type I+II (OMC, 18 patients), Sellors type III (OMC, 13 patients) and Sellors type III (MVR, 17 patients). Bjork-Shiley disc prosthetic valves were used in most of the MVR cases. Although the incidences of the NYHA Class (III+IV) in the Sellors type I+II, Sellors type III and MVR groups were 44.4% , 76.9% and 64.7%, respectively, before surgery, they improved to 0%, 15.4% and 5.9% postoperatively. No remarkable changes in the CI of the Sellors type I+II and Sellors type III groups were recognized through the entire postoperative period, but in the MVR group, both the CI and SVI increased significantly 6 months after the operation compared to preoperative values. The postoperative LV function at rest was best in the Sellors type I+II group (OMC), moderate in the MVR group and worst in the OMC patients of the Sellors type III group. The same results were recognized when scored using the NYHA functional classification. Six months after the operation, both the CI and SVI during exercise markedly decreased in the Sellors type III and MVR groups, and no improvement in the exercise tolerance of either group was recognized. Also, the Heather index increased significantly in comparison with preoperative values. Therefore, improvement in LV contractility and exercise tolerance hoped for in valvular reconstructive surgery was not realized. On the contrary, there was a tendency to become worse at the 6th postoperative month. It is difficult to decide whether to reconstruct or to replace a severely distored mitral valve. Considering the above results, we conclude that OMC of a remarkably distored valve was not necessarily indicated since the possibility of postoperative restenosis and regurgitation is rather high. In light of postoperative LV function and exercise tolerance, MVR seems preferable to OMC.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">OMC &amp; MVR</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Impedance cardiography</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Isometric handgrip exercise</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">左心機能</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">運動耐容能</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>ループス腎炎の免疫学的研究 第2編 ―Raji cell radioimmuno assayによる血中免疫複合体と腎組織における顆粒状沈着物の関連について―</ArticleTitle>
    <FirstPage LZero="delete">545</FirstPage>
    <LastPage>553</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Makoto</FirstName>
        <LastName>Kinashi</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>Using the Raji cell radioimmunoassay of Theofilopoulos et al, soluble immune complex (IC) in sera from 26 patients with systemic lupus erythematosus was measured. The distribution and amount of renal immune deposits were examined. According to the distribution of glomerular immune deposits, patients were divided into four groups. There were 3 patients with the focal segmental mesangial pattern, 8 with the diffuse global mesangial pattern, 11 with the granular pattern and 4 with the membranous pattern. In 2 of the 3 patients with the focal segmental mesangial pattern, serum IC levels were only slightly elevated and mesangial immune deposits were very light. In 7 of the 8 patients with the diffuse global mesangial pattern, serum IC levels were markedly elevated with large amount of mesangial glomerular immune deposits in spite of minimal urinary finding. In patients with this pattern, wide deviation of serum IC levels was observed. In 7 of the 11 patients with the granular pattern, marked elevation of serum IC levels was observed. Three patients with sclerotic glomerurlar changes had relatively low serum IC levels. In 3 of the 4 patients with the membranous pattern, serum IC levels were low. Of the 26 patients of this study, 12 having renal interstitial deposits had higher serum IC levels than 14 patients without renal interstitial immune deposition. This difference was statistically significant. There were no relationships between the serum IC levels and the grade of hematuria or proteinuria. The data suggests that the serum IC levels measured by the Raji cell radioimmunoassay may give us some information about the degree of renal immune deposition and become a useful index of lupus nephritis.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">ループス腎炎</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">免疫複合体</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ラージ細胞ラジオイムノアッセイ</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">全身性エリテマトーデス</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>ループス腎炎の免疫学的研究 第1編 ―Raji cell radioimmunoassayの基礎的検討―</ArticleTitle>
    <FirstPage LZero="delete">535</FirstPage>
    <LastPage>544</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Makoto</FirstName>
        <LastName>Kinashi</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>Using the Raji cell radioimmunoassay (RCRIA) reported by Theofilopoulos et al., 26 serum samples from systemic lupus erythematosus (SLE) patients were evaluated. All of those patients had definite granular immune deposits in renal biopsy specimens, and the presence of circulating immune complex in these patients was also suspected. RCRIA values of these patients were generally higher than those of normal human sera. RCRIA values were compared with other serological parameters of SLE including serum complement (CH(50)), serum gammaglobulin, anti-double stranded DNA antibody, anti-nuclear ribonucleoprotein (RNP) and anti-lymphocyte antibody. There was no correlation between the RCRIA values and anti-lymhocyte antibody. The correlation with CH(50) was also rather negative. There was positive correlations between the RCRIA values and serum gammaglobulin and anti-ds DNA antibody. However there were four serum samples which were negative to anti-ds DNA antibody but high RCRIA values. Three samples had high anti-RNP antibody titiers. The data suggest that not only the ds-DNA antigen-antibody system, but also other kinds of antigen-antibody systems may compose the circulating immune complex. The RCRIA values of sera from SLE patients using Raji cells killed by 100 % acetone instead of living cells were generally higher. The increases in the RCRIA values were regarded as being due to the participation of anti-nuclear antibodies present in the patients' sera. Thus, in evaluating SLE sera, there is the possibility that the RCRIA may give false positive results due to the presence of antibodies, including antinuclear antibodies, which react with Raji cells. As long as this possibility is kept in mind, the RCRIA value may become a valuable serological index of SLE.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">ループス腎炎</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">免疫複合体</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ラージ細胞ラジオイムノアッセイ</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">全身性エリテマトーデス</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>アルキル化剤Ifosfamideに関する臨床的研究 第2編 Ifosfamideおよびその活性代謝物4-hydroxy-ifosfamideの生体内動態よりみたIfosfamideの投与法に関する検討</ArticleTitle>
    <FirstPage LZero="delete">517</FirstPage>
    <LastPage>533</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Junichi</FirstName>
        <LastName>Harada</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>A new method for quantitative analysis of ifosfamide and its active metabolite, 4-hydroxy-ifosfamide, was applied to determine the optimal mode of administration of ifosfamide. Three each of six patients with extensive bronchogenic carcinoma were given a single 40mg/kg dose of ifosfamide by either a five-minute or 60-minute intravenous infusion, with a second course of treatment 7-21 days later. Using the NaOH method, the pharmacokinetics was investigated to determine which administration schedule, the five-minute or 60-minute infusion, was preferable for the treatment of clinical malignancies. Ifosfamide was quite stable, but 4-hydroxy-ifosfamide was labile in blood samples, though immediate extraction with dichlorethane minimized the lability of 4-hydroxy-ifosfamide. The distribution volume and the transfer constant into 4-hydroxy-ifosfamide of ifosfamide were rather large, while the transfer constant for urinary excretion was rather small after the 60-minute infusion. The amount of unchanged ifosfamide excreted into urine was larger and its excretion more rapid after the five-minute infusion. As for 4-hydroxy-ifosfamide, the elimination constants and the maximum concentration in the blood were similar for both schedules, but the distribution volume was larger after the 60-minute infusion. The urinary excretion of 4-hydroxy-ifosfamide was delayed and the ratio of 4-hydroxy-ifosfamide to unchanged ifosfamide was larger after the 60-minute infusion. These results suggest that the 60-minute intravenous infusion is preferable to the five-minute intravenous infusion.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">ifosfamide</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">pharmacology</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>アルキル化剤Ifosfamideに関する臨床的研究 第1編 肺癌および転移性肺腫瘍患者に対するIfosfamideの臨床効果と毒性に関する検討</ArticleTitle>
    <FirstPage LZero="delete">507</FirstPage>
    <LastPage>516</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Junichi</FirstName>
        <LastName>Harada</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>A total of 55 patients were treated with ifosfamide on two different treatment schedules. Twenty-four patients (22 with bronchogenic carcinomas and two with metastatic lung tumors) received 50 mg/kg of ifosfamide each day for three consective days, every three weeks (Regimen I), and the remaining 31 patients (24 with bronchogenic carcinomas and seven with metastatic lung tumors) received 40 mg/kg each day for five consective days, every three weeks (Regimen II). All patients had disseminated cancer, and 20 had had prior chemotherapy. Of the 20 evaluable patients with bronchogenic carcinoma who underwent Regimen I, five patients with small cell carcinoma had positive responses (one complete and four partial), whereas seven patients with other histologic cell types did not respond to the treatment. Of two metastatic lung tumor patients under Regimen I, one with cervical carcinoma had a partial response. The overall response rate for Regimen I was 6/22 (27%). With Regimen II, of 22 evaluable patients with bronchogenic carcinoma, nine (seven with small cell carcinoma, one with adeno carcinoma and one with squamous cell carcinoma) had partial responses. Of seven evaluable patients with metastatic lung tumor, two patients with cervical carcinoma had positive responses (one complete and one partial). The overall response rate for Regimen II was 11/29 (38%). Myelosupressive toxicity was mild: leukopenia (less than 2,000/cmm) occurred in 12% of the patients under Regimen I and 6% under Regimen II, and thrombocytopenia (less than 100,000/cmm) in 12% under Regimen I and 3% under Regimen II. Bladder toxicity occurred in 50 % of the patients under Regimen I and 52% under Regimen II. Upper gastrointestinal symptoms, such as nausea and vomiting occurred in one half of the patients under either Regimen. In conclusion, there were no significant differences in response rate and toxicity between the two treatment schedules. Ifosfamide appears effective in the management of disseminated cervical carcinoma, as well as small cell lung carcinoma. The agent should be considered in combination with other active agents in the treatment of bronchogenic carcinoma.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Ifosfamide</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">lung cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">metastatic lung tumor</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>岡山県の三地区(作東町,山陽町,長船町)の循環器疫学調査 第6報,昭和56年度の年齢,性別,内科診断別,HDL-コレステロール値の検討.</ArticleTitle>
    <FirstPage LZero="delete">497</FirstPage>
    <LastPage>506</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Shoichi</FirstName>
        <LastName>Haraoka</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Hidenori</FirstName>
        <LastName>Yoshida</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Daiji</FirstName>
        <LastName>Saito</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Nobuyuki</FirstName>
        <LastName>Yamada</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Kazuo</FirstName>
        <LastName>Ihoriya</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Akinobu</FirstName>
        <LastName>Fujii</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Toshiaki</FirstName>
        <LastName>Uchida</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Masashi</FirstName>
        <LastName>Kimura</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Ko</FirstName>
        <LastName>Takeda</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Masanobu</FirstName>
        <LastName>Nishihara</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Tatsuo</FirstName>
        <LastName>Hyodo</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Yukihiro</FirstName>
        <LastName>Abe</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Shigeaki</FirstName>
        <LastName>Ohnishi</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Takeshi</FirstName>
        <LastName>Minato</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>A cardiovascular epidemiologic survey was performed in three areas (Sakuto-cho, Sanyo-cho and Osafune-cho) of Okayama prefecture in 1981 to determine age and sex differences in serum HDL-and total-cholesterol. A total of 1077 subjects, 389 male and 688 female, with 412 under 60 years of age (younger group) and 655 over 60 years of age (elder group) were studied, and the following results were obtained. The ratio of HDL-cholesterol to total-cholesterol in subjects from the mountain town of Sakutocho was higher than in those from urban areas (Sanyo-cho and Osafune-cho). In the female group, HDL-and total-cholesterol values were higher and the HDL-/total-cholesterol ratio lower than in the male group. Among healthy individuals, the value of HDL-cholesterol was higher in the younger and female groups. However, in the female group, the total-cholesterol value was also high, so there was no significant difference between sex concerning the HDL-cholesterol to total-cholesterol ratio. In those with hypertension, ECG abnormalities and obesity, we found a higher total cholesterol level and lower HDL-cholesterol to total-cholesterol ratio than in the healthy subjects. This tendency was especially remarkable in the elder group. We found no differences in the HDL cholesterol values according to sex and age. However there was lower HDL-cholesterol to total-cholesterol ratio in the female group than in the male group resulting from a higher total-cholesterol value in the former.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">循環器疫学調査</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">HDL-コレステロール</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">高血圧</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">虚血性心疾患</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Atherogenic Index</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>右室心筋酸素代謝に関する実験的検討:左室心筋酸素代謝との比較</ArticleTitle>
    <FirstPage LZero="delete">487</FirstPage>
    <LastPage>496</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Shozo</FirstName>
        <LastName>Kusachi</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>A comparison of blood flow and myocardial oxygen consumption (MVO2) in the right and left ventricles was made in 24 open-chest dogs. Simultaneous measurements were made of the left anterior descending (LAD) and right coronary arterial (RC) blood flow, and of O(2) saturation in the coronary sinus and in from one to four anterior cardiac veins. Blood flow was greater in the LAD than in the RC, 87.4±36.0 and 46±22.0 ml/min/100g, respectively. The O(2) extraction was 51.3±11.0 in the anterior cardiac veins and 60.0±6.3% in the coronary sinus. The mean MVO(2) was greater for the left than for the right ventricles, 8.6±3.3 vs. 4.0±2.1 ml/min/100g. An increase in LAD flow without an increase in O(2) extraction accounted for the enhancement of MVO(2) of the left ventricle induced by pacing, isoproterenol or methoxamine. In contrast, pacing, isoproterenol or constriction of the pulmonary artery increased MVO(2) of the right ventricle with an increase in both O(2) extraction and right coronary blood flow. These results indicate that the right coronary arterial blood flow is lower per unit weight of tissue and is less dependent on MVO(2) than is LAD blood flow.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">myocardial O(2) metabolism</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">right and left ventricles</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">coronary flow</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">anterior cardiac veins</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>合成ペプタイドBT-PABAの経口投与による膵外分泌機能検査(PFT)に関する研究 第2編 PS試験との対比によるPFTの診断能とその限界に関すろ検討</ArticleTitle>
    <FirstPage LZero="delete">477</FirstPage>
    <LastPage>486</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Tetsumasa</FirstName>
        <LastName>Shundo</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>A comparative study of a pancreatic function test utilizing a synthetic peptide(PFT) and the pancreozymin secretin test (PS test) was performed to evaluate the validity and limitations of PFT. PFT was found to be less sensitive than the PS test in detecting exocrine pancreatic dysfunction. PFT values were always abnormal when the exocrine pancreatic dysfunction was moderate to severe; i.e., the amylase output 40,000 units, maximal bicarbonate concentration 70 mEg/l and secretory volume 55 ml. When the pancreatic dysfunction was of a milder degree, PFT values were abnormal only half of the time. Consequently, a normal PFT value does not necessarily rule out pancreatic disease. PFT can give a false positive result in cases of cirrhosis of the liver, irritable bowel syndrome and renal insufficiency. When renal insufficiency is ruled out, a PFT value of less than 65 percent is diagnostic of pancreatic dysfunction. A PFT value of 65-70 percent can be obtained in diseases of other organs such as cirrhosis of the liver and irritable bowel syndrome. PFT is not as sensitive as the PS test, but it is a simple and useful exocrine pancreatic function test. It is an especially good screening test for
pancreatic diseases.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">PFT</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">PS試験</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>合成ペプタイドBT-PABAの経口投与による膵外分泌機能検査(PFT)に関する研究 第1編 各種膵疾患における診断能の検討―手術所見および内視鏡的膵管造影像との対比を中心に―</ArticleTitle>
    <FirstPage LZero="delete">467</FirstPage>
    <LastPage>476</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Tetsumasa</FirstName>
        <LastName>Shundo</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>A pancreatic function test (PFT) by peroral intake of a synthetic peptide (N-benzoyl-L-tyrosyl-P-aminobenzoic acid) was performed on 29 healthy controls and 131 patients with various pancreatic diseases in order to evaluate its validity and limitations. PFT was found to be a simple and useful exocrine pancreatic function test with good reproducibility. PFT values were significantly lower in patients with noncalcified chronic pancreatitis, pancreatolithiasis, pancreatic cancer, pancreatectomy or acute pancreatitis than in healthy controls. Furthermore PFT values were abnormal in 13.6 percent of 22 patients with suspected chronic pancreatitis, 78.1 percent of 32 patients with noncalcified chronic pancreatitis, 81.5 percent of 27 patients with pancreatolithiasis and 88 percent of patients with pancreatic cancer. Mild damage of the pancreas could not be detected by PFT, though moderate to severe damage could be in most cases. As for pancreatic cancer, the PFT values were not abnormal unless the main pancreatic duct was obstructed within 6 cm of the Vaterian papilla, and as for chronic pancreatitis, values were abnormal only when dilatation of the pancreatic duct was accompanied by stenosis, irregular margin, rigidity and/or obstruction. Evaluation of patients who had undergone a pancreatectomy indicated that PFT values were abnormal when more than the proximal half or the distal three-fourths of the pancreas was resected. PFT was useful in following up recovery from acute pancreatitis. PFT is slightly less sensitive than the pancreozymin secretin test in detecting exocrine pancreatic dysfunction, and a normal PFT value does not necessarily rule out pancreatic disease.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">PFT</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ERCP</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">膵部分切除</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>各種刺激物質による肥満細胞の(45)Ca uptakeとCa(2+)拮抗剤</ArticleTitle>
    <FirstPage LZero="delete">459</FirstPage>
    <LastPage>465</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Yoshiro</FirstName>
        <LastName>Tanizaki</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Haruki</FirstName>
        <LastName>Komagoe</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Michiyasu</FirstName>
        <LastName>Sudo</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Jun</FirstName>
        <LastName>Ohtani</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Hikaru</FirstName>
        <LastName>Kitani</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Yohko</FirstName>
        <LastName>Matsuka</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Ikuro</FirstName>
        <LastName>Kimura</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Katsumi</FirstName>
        <LastName>Akagi</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N"/>
        <LastName/>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>(45)Ca uptake by rat peritoneal mast cells was observed, and the inhibitory effect of nifedipine, a Ca(2+) antagonist, on (45)Ca uptake by mast cells, stimulated by an antigen, comp. 48/80, concanavalin A and Ca ionophore A 23187, was examined. The increase in (45)Ca uptake by mast cells induced by the antigen paralleled the increase in mast cell number. A significant increase in the uptake of (45)Ca by mast cells was observed with the stimulation by the antigen, comp. 48/80, concanavalin A and Ca ionophore A 23187. The increased uptake of (45)Ca induced by antigen was inhibited by nifedipine, and this dose-dependent inhibitory effect of nifedipine on (45)Ca uptake was also observed in the mast cells stimulated by comp. 48/80, concanavalin A and Ca ionophore A 23187.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">肥満細胞</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">(45)Ca uptake</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ca(2+)拮抗剤</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>側頭骨含気蜂巣の年齢変化 ―奇形耳と正常耳の比較―</ArticleTitle>
    <FirstPage LZero="delete">449</FirstPage>
    <LastPage>457</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Nobuaki</FirstName>
        <LastName>Takata</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>This study was undertaken to clarify the characteristics of pneumatization with aging by measuring the area of temporal pneumatizations of malformed ears as shown in roentgenograms. Roentgenograms of 23 patients afflicted unilaterally and 8 bilaterally with congenital atresia auris with microtia were examined. These patients, aged 3 to 27 years, were admitted to the Department of Otolaryngology, Okayama University Medical School Hospital for surgical treatment from January 1953 to Novembar 1978. A considerable number of X-ray photographs of normal ears of outpatients of the same hospital were used for statistical comparison during the same period. It was revealed that the area of pneumatization was statistically smaller in the malformed ear, and that the correlation between the area of pneumatization and age was high in the nomal ear. There was some difference between the bitateral and unilateral cases as to the mode of the development. In bilateral cases, it was thought that the development of pneumatization might have occurred during the embryonal stage and be attributable to congenital causes. Pneumatization in unilateral cases might have been influenced strongly by postnatal suppression.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">側頭骨含気蜂巣</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">伝音系奇形耳</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">鎖耳患者</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">先天性鎖耳</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>ジギトニン処理permeable腹水肉腫細胞におけるミトコンドリアの酸化的リン酸化</ArticleTitle>
    <FirstPage LZero="delete">437</FirstPage>
    <LastPage>447</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Tsuguya</FirstName>
        <LastName>Shigehara</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>ラウス肉腫ウィルス誘発腹水肉腫細胞(SR-C3H/He)を低濃度のジギトニン(終末0.01%)で処理し,基質透過性細胞とすることにより,少量の材料で簡単にミトコンドリアの呼吸速度,呼吸調節率(RCR),酸化的リン酸化能(ADP/0 比)などの機能を酸素電極法を用いて調べられることがわかった.この基質透過性腹水肉腫細胞ではマウス肝や腹水肉腫細胞から分離したミトコンドリアより,呼吸調節率や酸化的リン酸化能が幾分低い.この原因について種々なATPase活性を検討した結果,この透過性細胞では主にミトコンドリア以外のMg(2+)-ATPase活性がかなり高く存在し,これによって呼吸調節率や酸化的リン酸化能の低下が生じることが示唆された.また,この透過性細胞に解糖系の基質であるグルコースやホスホエノールピルビン酸を添加しhexokinaseやpyruvate kinaseの存在による呼吸調節への影響を認めたが,解糖系の一連の反応は不連続であり,呼吸調節率や酸化的リン酸化能の低下の主因であるとは考え難い.このように,低濃度のジギトニン処理透過性細胞は比較的少量のwhole cellでのミトコンドリアの酸化的リン酸化と呼吸阻害剤や脱共役剤の影響を簡便に調べることができ,さらに細胞内オルガネラの機能と代謝系の相関をin vivoに近い条件下で調べることのできるきわめて有用な実験系であると考えられる.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">ミトコンドリア</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">透過性細胞</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">酸化的リン酸化</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ATPase</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ジギトニン</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>抗腫瘍抗体結合抗癌剤の研究 第2編 抗腫瘍抗体結合Neocarzinostatin(NCS-immune IgG)のin vivo抗腫瘍効果</ArticleTitle>
    <FirstPage LZero="delete">429</FirstPage>
    <LastPage>436</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Yuji</FirstName>
        <LastName>Sato</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>The in vivo antitumor activity of NCS-immune IgG (NCS conjugated with rabbit IgG antibody against the human leukemia cell line NALL-1) was evaluated in immunosuppressed newborn Syrian hamsters implanted with a transplantable human leukemia cell line (BALL-1). After i.p. injection of the conjugate, hamsters preinoculated i.p. with BALL-1 cells survived longer than hamsters treated with control solutions (p&lt;0.01). The control solutions included NCS, immune IgG, a mixture of NCS and immune IgG, NCS-normal IgG conjugate and physiological saline. Growth retardation was not observed in NCS-immune IgG treated hamsters. The growth of s.c. implanted BALL-1 tumors was inhibited by i.p. administrations of NCS-immune IgG, however, the degree of inhibition was not significantly different from that obtained by NCS alone, a mixture of NCS and immune IgG or NCS-normal IgG conjugate. These results indicate that NCS-immune IgG was effective against i.p. implanted BALL-1 tumors, but was no so effective against s.c. implanted tumors.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Antibody-NCS conjugate</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">In vivo antitumor activity</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Transplantable human leukemia cells</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>Histamineとその類似化合物のモルモット顎下腺に対するcyclic AMP増加作用</ArticleTitle>
    <FirstPage LZero="delete">421</FirstPage>
    <LastPage>428</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Masato</FirstName>
        <LastName>Murakami</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>モルモット顎下腺切片のcyclic AMP含量に及ぼすhistamineとその類似化合物の効果,およびこの効果に対するhistamine拮抗薬ならびにhistamine代謝酵素阻害薬の影響をしらべ,次の成績を得た.1) 被検のhistamine受容体活性薬はcyclic AMPレベルを用量依存的に上昇させた.histamineと4-methylhistamineのED(50)値はそれぞれ約1.3×10(-5)Mおよび2.2×10(-5)Mであった.4-methylhistamineの最大効果はhistamineのそれを上回った.2) 2-(2-pyridyl)ethylamineはhistamineや4-methylhistamineと比較して,効果がはるかに劣っていた.3) metiamideはhistamineおよび4-methylhistamineによるcyclic AMPレベルの上昇を著しく抑制した.しかし, mepyramineは無効であった.4) aminoguanidineとquinacrineの併用は, histamineのcyclic AMPレベル上昇効果に対して影響を及ぼさなかった.以上の成績は,モルモット顎下腺には, cyclic AMP増加を媒介するH(2)型のhistamine受容体が存在することを示唆する.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Submandibular gland</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Histamine H(2) receptor</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cyclic AMP</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Metiamide</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mepyramine</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>ネコの非律動的不随意運動発現に関与する神経路に関する研究</ArticleTitle>
    <FirstPage LZero="delete">405</FirstPage>
    <LastPage>419</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Yoshikazu</FirstName>
        <LastName>Yoshimura</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>An electrode was implanted to stimulate unilaterally the mesencephalic ventromedial tegmentum (VMT) in 27 adult cats. Abnormal involuntary movements (AIM) such as contraversive head turning, bucco-lingual movements and choreoathetoid movements of the contralateral forelimb were elicited by high frequency electrical stimulation (20-100 Hz); the cats were unrestrained. Such AIM were abolished by damaging the thalamic ventrolateral nucleus ipsilateral to the stimulated side. In order to investigate the neural pathway related to AIM, kainic acid (2μg) was injected stereotaxically into either the caudate nucleus or the globus pallidus in cats which had AIM during electrical stimulation of the VMT. These experimentally produced AIM did not changed with injection of kainic acid into the ipsilateral anteroventral part of the caudate uncleus, but were abolished by injection either into the ipsilateral rostromedial part of the caudate nucleus or into the globus pallidus. It was confirmed histologically that the intracerebral microinjection of kainic acid produced degeneration of nerve cell bodies and dendrites near the injection site while not affecting axons terminating in or passing through it. These results suggest that the neural pathway arising from the substantia nigra and leading to the ventrolateral thalamus via the rostromedial part of the caudate nucleus and the globus pallidus are essential in producing AIM by electrical stimulation of VMT, and that this neural pathway contains at least one synapse each within the caudate nucleus and the globus pallidus.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">dyskinesia</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">mesencephalic</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">vertromedial tegmentum(VMT)</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Kainic acid</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName>岡山医学会</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>0030-1558</Issn>
      <Volume>95</Volume>
      <Issue>5-6</Issue>
      <PubDate PubStatus="ppublish">
        <Year>1983</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>頭頸部癌の再建外科・術式及び成績</ArticleTitle>
    <FirstPage LZero="delete">395</FirstPage>
    <LastPage>403</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Shuichi</FirstName>
        <LastName>Watanabe</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Rhusuke</FirstName>
        <LastName>Saito</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Toshiaki</FirstName>
        <LastName>Ogawara</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Yoshio</FirstName>
        <LastName>Ogura</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Makoto</FirstName>
        <LastName>Kanatani</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Yuzuru</FirstName>
        <LastName>Matsubara</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Satoshi</FirstName>
        <LastName>Koike</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>Various surgery techniques performed on 26 advanced cancer patients using forehead, deltopectoral(D-P) and musculocutaneous(M-C) flaps were reviwed. The D-P flap presents few cosmetic problems in the head and neck region and can be used in elder patients because of little operative invasion. The M-C flap allows for reconstruction of defects in a one-stage operation which may shorten hospitalization and permit an ealier return to social life. The forehead flap is the most durable and reliable flap among them for reconstructive surgery, though it offers some cosmetic problems. In reconstruction of the esophagus after a pharyngolaryngoesophagectomy for cancer of the hypopharynx and the cervical esophagus, it seems more advantageous to use a hige flap in reconstruction than Bakamjian's original method since early detection of a local recurrence of the tumor is rendered easier with the former. There were no fatal postoperative complication, though minor necrosis, fistula, suture insufficiency and esophageal stenosis were observed, but improved with conservative treatment. Conseqently, the reliability and versatility of pedicle and muculocutaneous flaps were confirmed. As to the prognosis, the 2-year survival rate was 42.2% . The cause of death was local recurrence in 4 patients, who all died within two years, and distant metastasis in 4 patients, who all died within one year of the operation. Local recurrence and distant metastasis were also seen in 4 patients who survived.</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">head and neck tumor</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MC flap</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">DP flap</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
</ArticleSet>
